ICO THERAPEUTICS
ICo Therapeutics is focused on the research and development of drug delivery technologies. By focusing efforts on development instead of research, iCo's business model aims to acquire the rights to drugs that are either off-patent, currently approved, or near commercialization and develop them by redosing or reformulating them for new or expanded labels. The subsequent development of these therapeutics may include drug delivery technologies-such as sustained-release or biodegradable matrices to extend patent coverage.
ICO THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2005-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.icotherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
604.602.9414
Email Addresses:
[email protected]
Total Funding:
8.58 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Gravatar Profiles GoDaddy WPForms
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-03-22 | Satellos Bioscience | Satellos Bioscience acquired by iCo Therapeutics | N/A |
Investors List
National Research Council of Canada Industrial Research Assistance Program
National Research Council of Canada Industrial Research Assistance Program investment in Grant - iCo Therapeutics
Official Site Inspections
http://www.icotherapeutics.com
- Host name: 195-154-48-61.rev.poneytelecom.eu
- IP address: 195.154.48.61
- Location: Avon France
- Latitude: 48.4022
- Longitude: 2.7202
- Timezone: Europe/Paris
- Postal: 77210
More informations about "iCo Therapeutics"
Corporate Overview - iCo Therapeutics
Jun 22, 2007 iCo Therapeutics is an emerging Vancouver-based biotechnology company committed to developing drugs for a range of human medical conditions within isolated …See details»
About - iCo Therapeutics
Satellos Bioscience - Crunchbase Company Profile & Funding
Organization. Satellos Bioscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; …See details»
iCo Therapeutics Inc. Announces TSX Venture Exchange …
Jul 9, 2021 Vancouver, BC– iCo Therapeutics Inc. (“iCo” or the “Company”) (TSXV: iCo) (OTCQB: iCoTF) is pleased to announce that the Company has received formal conditional …See details»
ICO Therapeutics Company Profile 2025: Valuation, …
ICO Therapeutics General Information Description. iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications.See details»
iCo Therapeutics Inc. - Vancouver, Canada - bionity.com
Apr 15, 2010 iCo Therapeutics Inc. is a Vancouver-based development based company focused on in-licensing drugs with clinical history redosing or reformulating for new or expanded …See details»
iCo Therapeutics Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for iCo Therapeutics Inc of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
iCo Therapeutics - LifeScienceHistory.com
Www.icotherapeutics.com. 777 Hornby St., 6th Floor. Vancouver, BC V6Z 2T3. Company Info Phone (647) 660-1780 Year Established 2005 Ticker ICO Exchange TSX. Contacts Frank …See details»
iCo Therapeutics receives funding from the Government of
May 31, 2012 For more information, visit the Company website at: www.icotherapeutics.com. ... Organization Profile. iCo Therapeutics Inc. Contact Cision. 866-245-2317 from 8 AM - 10 PM ETSee details»
ICO THERAPEUTICS INC - VentureRadar
Website: http://www.icotherapeutics.com/ iCo Therapeutics was founded to tackle specific, global health issues by rethinking existing pharmaceutical candidates for ...See details»
iCo Therapeutics Inc. Announces Shareholder Approval of Business ...
Aug 5, 2021 Vancouver, British Columbia--(Newsfile Corp. - August 5, 2021) - iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or the "Company") is pleased to announce that at an …See details»
Ico Therapeutics Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ico Therapeutics Inc. of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
iCo Investor Information: News - iCo Therapeutics
Dec 31, 2020 Title Date; iCo Therapeutics Inc.: Carc – Online Pharmacy Services and Canadian Drugs: July 18, 2024: iCo Therapeutics, Inc. announces agreement for in vivo testing of iCo- …See details»
Nextsource | Company Profile | ICo Therapeutics
Explore the company profile of ICo Therapeutics (icotherapeutics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
iCo Therapeutics Oral Amphotericin Program Receives FDA …
Sep 30, 2010 VANCOUVER, BRITISH COLUMBIA, Sep 29, 2010 (MARKETWIRE via COMTEX) -- iCo Therapeutics Inc. is pleased to announce that the Company's oral …See details»
iCo Therapeutics, Inc. - discovery.patsnap.com
ICo Therapeutics, Inc. is a company that provides Medicine, Pharmacy and Therapeutics, Drug and more. iCo Therapeutics, Inc. is headquartered in Canada British Columbia. iCo …See details»
iCo Therapeutics Inc. Executes Bertilimumab License with Immune ...
Jun 24, 2011 VANCOUVER, Canada - iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce that Immune Pharmaceuticals (IMMUNE) has licensed Bertilimumab (iCo-008) for …See details»
ICO THERAPEUTICS INC - VentureRadar
Website: http://www.icotherapeutics.com/ Offers innovative solutions for global health issues by reinventing, repositioning, and reformulating existing pharmaceutical ...See details»
What Is An Initial Coin Offering (ICO)? - Forbes
Mar 23, 2025 What Is An Initial Coin Offering (ICO)? An Initial Coin Offering (ICO) is a fundraising method where a company or development team offers digital tokens to the public …See details»
iCo Therapeutics Inc.
Sep 29, 2017 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»